Bloomberg -- Pfizer Inc.’s Lipitor, AstraZeneca Plc’s Crestor and rival drugs to lower cholesterol also boost diabetes rates by about 9 percent, according to a study that quantified a complication that doctors only recently discovered.
Bloomberg -- Pfizer Inc.’s Lipitor, AstraZeneca Plc’s Crestor and rival drugs to lower cholesterol also boost diabetes rates by about 9 percent, according to a study that quantified a complication that doctors only recently discovered.
